On the evolution of 'Indian Bison type' strains of Mycobacterium avium subspecies paratuberculosis

J S Sohal1, S V Singh, P K Singh

  • 1Microbiology Laboratory, Central Institute for Research on Goats, Makhdoom, PO-FARAH, District Mathura (UP), India.

Insights

Mycobacterium avium subspecies paratuberculosis (MAP) causes Johne's disease in animals and is linked to Crohn's disease in humans. This study reveals recent molecular evolution in the prevalent

Area of Science:

  • Veterinary microbiology
  • Molecular epidemiology
  • Infectious diseases

Background:

  • Mycobacterium avium subspecies paratuberculosis (MAP) is the etiological agent of Johne's disease (JD) in ruminants.
  • MAP has been implicated in Crohn's disease (CD) in humans, necessitating further research into its genetic diversity.
  • Control of JD in India is hindered by a lack of indigenous diagnostics and vaccines.

Purpose of the Study:

  • To investigate the molecular evolution of MAP strains, particularly the 'Bison type' genotype.
  • To understand the genetic basis of the predominant 'Indian Bison type' MAP strain circulating in India.
  • To provide insights for developing effective control strategies against MAP infections.

Main Methods:

  • Genotyping of MAP strains using IS1311 PCR-REA.
  • Analysis of specific genetic markers in native MAP isolates.
  • Comparative analysis of genetic data for evolutionary inferences.

Main Results:

  • The study focused on the understudied 'Bison type' MAP genotype.
  • A new 'Indian Bison type' genotype has been identified as the principal strain in India, infecting various animal species and humans.
  • Analysis of genetic markers suggests recent evolutionary origins for the 'Bison type' genotype.

Conclusions:

  • The 'Indian Bison type' MAP genotype represents a recently evolved lineage.
  • Understanding the molecular evolution of MAP is crucial for disease control and public health.
  • Further research into MAP's genetic diversity can inform diagnostic and vaccine development.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Evolution of New Traits in Microbes01:24

Evolution of New Traits in Microbes

Microorganisms evolve rapidly due to their large population sizes and short generation times, often exhibiting measurable changes within days under laboratory conditions. Natural selection acts on standing genetic variation, enabling the retention and amplification of beneficial traits that confer fitness advantages in changing environments.Adaptive Pigment Regulation in RhodobacterIn Rhodobacter, a genus of purple non-sulfur bacteria, light-harvesting pigments such as bacteriochlorophyll and...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: